AI & Software Platforms

Skin Analytics' DERM Zero is the first AI to get Class III certification for autonomous skin cancer checks on a smartphone, promising to transform access.

A new platform, MyIQ, is betting that we're ready to trade one-time scores for continuous self-discovery. But can a strategy of depth win in a shallow world?

A recent Hong Kong summit unveiled a new frontier: tokenizing everyday consumption. Behind the buzz, a strategic play to build the rails for a new digital economy is underway.

AutoZone adds $1.5B to its colossal buyback program. We dissect if this relentless return of capital is a masterstroke or a sign of a company running out of road.

With the UK capping casino bonus wagering at 10x, the game has changed. Jack Patterson examines the new rules and the tech making betting safer.

Biotech firm Azitra is leveraging its engineered microbe tech to tackle rare diseases and enter the $71B cosmeceutical market. Is this a brilliant pivot or a risky bet?

The AI revolution runs on more than code. Soaring energy demand and a critical copper shortage are creating a physical bottleneck that could reshape the industry.

With streaming now its top revenue source, AMC brings in Hozefa Lokhandwala, a Wall Street and media veteran, to fortify its IP-driven strategy.

JFB Construction is swapping blueprints for battle plans in a stunning merger with AI robotics firm XTEND. We dig into the $1.5B deal creating a new defense powerhouse.

The instant success of 'Return to Silent Hill' isn't just about horror. It’s a masterclass in Cineverse's strategy of marrying cult IP with AI precision.

Verastem Oncology's new drug enters a pivotal trial for pancreatic cancer, targeting a notorious mutation with a novel dual-action mechanism.

Univers's new platform isn't just another AI. It's a move to give our physical world—from power grids to ports—a continuously learning, autonomous brain.

KPMG is betting big on AI to fix audit quality in Hong Kong. But as the firm champions a 'Trusted AI' future, can it overcome the hidden perils of the technology it promotes?

The insurer's expansion isn't just about a new state. It's a strategic fusion of InsurTech speed and century-old underwriting to tackle complex risks.

A federal court sided with marine marketplace giant Boats Group, dismissing an antitrust suit. We deconstruct the ruling and what it means for tech titans.

We're all ignoring unknown calls. A new report sheds light on why, revealing a deep-seated digital caution that is creating a multi-billion dollar market for trust.

A new report claims real inflation is triple the official rate. We dissect the growing chasm between government data and the reality for your wallet.

A $1.2M seed round for orthopaedic AI firm Maia isn't just startup news. It signals a systemic shift from generalist AI to specialized digital engines.

A new alliance between Sun Life and Medzown moves beyond financial safety nets, using AI to steer patients to clinical trials and reshape corporate healthcare.

Australian healthtech Everlab secures a huge Series A to take its AI-driven preventative care platform global. Can it remake healthcare or will data and regulation stall it?